You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
完美醫療(01830.HK)中期純利上升59.6%至2.16億港元 中期息17.7港仙
格隆匯 11-29 08:08

格隆匯11月29日丨完美醫療(01830.HK)發佈公吿,截至2021年9月30日止六個月,集團收益增加57.2%至8.016億港;除利息、税項、折舊及攤銷前盈利上升48.9%至3.772億港元;純利上升59.6%至2.164億港元,純利率為27.0%;每股基本盈利上升46.3%至17.7港仙;擬宣派中期股息每股股份17.7港仙,其將以現金支付。

回顧期間,按地區劃分,中國香港業務是集團的最大經營分部,佔集團營業額約78.3%(2020╱21財政年度中期:64.4%)。回顧期間,中國香港的銷售額上升91.1%至約6.275億港元(2020╱21財政年度中期:3.283億港元),而回顧期間,中國大陸、中國澳門、澳洲及新加坡地區的銷售額則輕微減少4.1%至約1.741億港元(2020╱21財政年度中期:1.815億港元)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account